Pharmaceutical laboratories, as well as hospital wards, carry out constant and significant research activities while searching for risk factors of pathologies or treatments which are meant to ameliorate or even cure them. To this purpose, laboratories and hospitals gather data about the incidence and behaviour of these pathologies in patients. ERATEMA carries out biostatistical research which meets the criteria of the nature of the research and provides results which impact the decision-making process.

Close interaction with the researcher is ERATEMA’s top priority throughout a project. Each of the steps of the project is validated in close collaboration between ERATEMA and the researcher.

INITIAL DESIGN
The researcher describes the project’s objectives and deadlines and ERATEMA will determine the type of study and the final time frame.

GATHERING OF DATA
Researchers can be assisted by ERATEMA regarding the data gathering and provide the final database or they may request ERATEMA’s field network to carry out the data gathering and the subsequent data recording.

STATISTICAL ANALYSIS
The researcher proposes the areas of interest, while ERATEMA lays out the most adequate statistical analysis plan; from this point, a constant flow of information between the researcher and ERATEMA is established in order to achieve the best possible results for the researcher.

FINAL PUBLICATION
ERATEMA’s technical personnel explains the results gathered to the researcher, and responds to all possible claims and doubts which may arise, subsequently advising and reviewing the final publication.

ERATEMA has carried out a vast amount of biostatistical research projects for laboratories and hospitals in fields such as dentistry, ophthalmology, or oncology. Some examples of projects in these fields are outlined below:

• Epidemiological investigation to assess pain management in oncology: This study determines the type of action needed in order to alleviate pain and obtain the maximum benefit for the patient’s quality of life, with special emphasis on the description and phenomenology of adverse effects.

• Impact of a probiotic treatment on microbiota and clinical research parameters: A classical prospective study of case control where the hypothetical benefits of a probiotic are evaluated versus placebo.

• Evaluation of macular degeneration in ophthalmology patients: The analysis of variance of repeated measurements concluded that treatment via photodynamic therapy can be significantly more efficient for a specific type of lesion.

METHODOLOGY